FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

David Coghill

Research Profile

Disorders

Attention Deficit Disorders with Hyperactivity

Chemicals & Drugs

Concepts & Ideas

Procedures

Physiology

Devices

Placebos

Geographic Areas

Europe

Co-author Network

Publications

TOP 3
Edmund J S Sonuga-Barke; Jim Stevenson; Saskia van der Oord; Ian C K Wong; Alessandro Zuddas; Tobias Banaschewski; Daniel Brandeis; Jan Buitelaar; David Coghill; Samuele Cortese; David Daley; Marina Danckaerts; Ralf W Dittmann; Manfred Döpfner; Maite Ferrin; Chris Hollis; Martin Holtmann; Eric Konofal; Michel Lecendreux; Joseph Sergeant; Emily Simonoff
Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments.
Susan Young; Clodagh M Murphy; David Coghill
Avoiding the 'twilight zone': recommendations for the transition of services from adolescence to adulthood for young people with ADHD.
Christine Cornforth; Edmund Sonuga-Barke; David Coghill
Stimulant drug effects on attention deficit/hyperactivity disorder: a review of the effects of age and sex of patients.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of David Coghill (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Edmund J S Sonuga-Barke; Jim Stevenson; Saskia van der Oord; Ian C K Wong; Alessandro Zuddas; Tobias Banaschewski; Daniel Brandeis; Jan Buitelaar; David Coghill; Samuele Cortese; David Daley; Marina Danckaerts; Ralf W Dittmann; Manfred Döpfner; Maite Ferrin; Chris Hollis; Martin Holtmann; Eric Konofal; Michel Lecendreux; Joseph Sergeant; Emily Simonoff
Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments.
The American journal of psychiatry 2013;170(3):275-89.
2011: Susan Young; Clodagh M Murphy; David Coghill
Avoiding the 'twilight zone': recommendations for the transition of services from adolescence to adulthood for young people with ADHD.
BMC psychiatry 2011;11():174.
2010: Christine Cornforth; Edmund Sonuga-Barke; David Coghill
Stimulant drug effects on attention deficit/hyperactivity disorder: a review of the effects of age and sex of patients.
Current pharmaceutical design 2010;16(22):2424-33.
2009: Edmund J S Sonuga-Barke; David Coghill; Marc DeBacker; James Swanson
Measuring methylphenidate response in attention-deficit/hyperactvity disorder: how are laboratory classroom-based measures related to parent ratings?
Journal of child and adolescent psychopharmacology 2009;19(6):691-8.
2009: Edmund J S Sonuga-Barke; David Coghill; Timothy Wigal; Marc DeBacker; James Swanson
Adverse reactions to methylphenidate treatment for attention-deficit/hyperactivity disorder: structure and associations with clinical characteristics and symptom control.
Journal of child and adolescent psychopharmacology 2009;19(6):683-90.
2008: Edmund J S Sonuga-Barke; Pol Van Lier; James M Swanson; David Coghill; Sharon Wigal; Mieke Vandenberghe; Simon J Hatch
Heterogeneity in the pharmacodynamics of two long-acting methylphenidate formulations for children with attention deficit/hyperactivity disorder. A growth mixture modelling analysis.
European child & adolescent psychiatry 2008;17(4):245-54.
2008: Xavier Gastaminza; Philip Hazell; Marina Danckaerts; Peter Hoare; David Coghill; Peter M Wehmeier; David W Williams; Rodney J Moore; Louise Levine
Atomoxetine for the treatment of attention-deficit/hyperactivity disorder and oppositional defiant disorder.
Pediatrics 2008;121(2):e314-20.
2007: Edmund J S Sonuga-Barke; David Coghill; John S Markowitz; James M Swanson; Mieke Vandenberghe; Simon J Hatch
Sex differences in the response of children with ADHD to once-daily formulations of methylphenidate.
Journal of the American Academy of Child and Adolescent Psychiatry 2007;46(6):701-10.
2006: Tobias Banaschewski; David Coghill; Paramala Santosh; Alessandro Zuddas; Philip Asherson; Jan K Buitelaar; Marina Danckaerts; Manfred Döpfner; Stephen Faraone; Aribert Rothenberger; Joseph Sergeant; Hans-Christoph Steinhausen; Edmund J S Sonuga-Barke; Eric Taylor
Long-acting medications for the hyperkinetic disorders. A systematic review and European treatment guideline.
European child & adolescent psychiatry 2006;15(8):476-95.
2004: Edmund J S Sonuga-Barke; James M Swanson; David Coghill; Heleen H DeCory; Simon J Hatch
Efficacy of two once-daily methylphenidate formulations compared across dose levels at different times of the day: preliminary indications from a secondary analysis of the COMACS study data.
BMC psychiatry 2004;4():28.
2004: Eric Taylor; Manfred Döpfner; Joseph Sergeant; Philip Asherson; Tobias Banaschewski; Jan K Buitelaar; David Coghill; Marina Danckaerts; Aribert Rothenberger; Edmund J S Sonuga-Barke; Hans-Christoph Steinhausen; Alessandro Zuddas
European clinical guidelines for hyperkinetic disorder -- first upgrade.
European child & adolescent psychiatry 2004;13 Suppl 1():I7-30.